HIGHLIGHTS
- who: Yu Mao from the United Kingdom Ankara University, Turkey have published the article: Safety, efficacy, and clinical outcomes of transcatheter tricuspid valve replacement: One-year follow-up, in the Journal: (JOURNAL)
- future: Research is needed to determine whether vitamin K antagonists direct oral anticoagulants or dual antiplatelet agents should be used. The further studies are needed to proceed.
SUMMARY
The prognosis of patients with severe TR is short of expectations, and the 5-year survival rate is less than 50%. The etiology of primary TR includes congenital tricuspid valve (TV . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.